Dextrose Hydrodissection for Post-Breast Cancer Chest Wall and Axillary Tightness.

The goal of this clinical trial (prospective case series) is to evaluate the feasibility, safety, and preliminary clinical outcomes of ultrasound-guided dextrose prolotherapy in female breast cancer survivors with persistent ipsilateral chest wall and axillary pain and tightness who have plateaued with standard physical therapy. The main questions it aims to answer are: Does ultrasound-guided dextrose prolotherapy significantly improve upper extremity functional limitation (measured by the QuickDASH questionnaire)? What are the effects of this intervention on pain intensity (NRS), active sh

Trial Details

NCT ID
NCT07378319
Phase
NA
Sponsor
Taichung Veterans General Hospital
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • ultrasound guided dextrose prolotherapy
Locations (sample)
  • Taichung, Taiwan, Taiwan|24.1469,120.6839

Key Eligibility Criteria

  • History of breast cancer surgery (mastectomy or breast-conserving surgery), with or without axillary lymph node dissection
  • Persistent ipsilateral chest wall and/or axillary pain, tightness, or movement restriction lasting ≥ 3 months after surgery;
  • Clinically significant baseline symptom severity, defined as Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire ≥ 25 and/or…
  • Completion of 12 weeks of standard physical therapy with no significant improvement, defined as a change in QuickDASH score from baseline to comple…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →